This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Littrell, K. H. Articles by Littrell, S. H. Search for Related Content Social Bookmarking                         What's this?

Choosing an Antipsychotic in the reatment of Schizophrenia: Conversions to Olanzapine

The Promedica Research Center, 3758 Lavista Rd., Suite 100, Tucker, GA 30084.

Steven H. Littrell, LPC, CGP, MA

The recent introduction of olanzapine (Zyprexa) has provided anotherfirst-line antipsychotic treatment option in the pharmacologic treatment ofpsycbiatric patients. Unlike clozapine which is restricted to use with refractory schizophrenia, olanzapine is labeledfor the management of manifestations of psychotic disorders This implies a much larger potential treatment population besides schizophrenia, and nurses should consider its use beyond patients with treatment-resistant schizophrenia Matters of therapeutic dosing, titration, and maintenance dosing are remarkably simple with this compound With the current availability of olanzapine, nurses will need to befamiliar with the issues surrounding conversion from other antipsycbotic agents to this new agent.

Journal of the American Psychiatric Nurses Association, Vol. 3, No. 1, S18-S23 (1997)
DOI: 10.1177/107839039700300112


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?